How DePasquale was paid
$309,491 in total for 2024, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Other | Total |
|---|---|---|---|---|
| Michael W. DePasqualeChief Executive Officer | $285,000 | $24,000 | $491 | $309,491 |
| Cecilia C. WelchChief Financial Officer | $199,500 | $22,500 | — | $222,000 |
| James D. SullivanChief Legal Officer | $223,250 | $22,500 | $79,429 | $325,179 |
What changed and why
- $285K$285,000 CEO salary and $24,000 restricted-stock award produced $309,491 total compensation in 2024.
- $292K$291,527 CEO total compensation was reported for 2023.
- $79,429$79,429 in other compensation for James Sullivan included $78,632 of sales commissions.
- 2024 restricted-stock awards recognized 2023 revenue growth for each named executive officer.
- Performance-based bonuses have historically depended on revenue milestones established by the compensation committee.
- Base compensation for the CEO, CFO and CLO was restored effective July 1, 2024.
Other Bio Key International proxy statements
- 2026 proxy statement
Michael W. DePasquale paid $346,824 (+12% on the year).
Filed Jul 24, 2026
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.